Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 225 results for "sun pharmaceutical industries"

Sun Pharma trades higher on the bourses

SENSEX 24035.78 251.64 1.04% NIFTY 7301.50 85.75 1.16% Industry: Medical/Healthcare Company Sun Pharmaceutical Industries Ltd Sun Pharmaceutical Industries is currently trading at Rs. 854.00, up by 17.90 points or 2.14% from ..., 12 hours ago

11 images for sun pharmaceutical industries

Sify, 1 week ago, 1 week ago, 1 week ago
Reuters, 1 week ago, 1 month ago
Financial Express, 1 week ago
India Infoline, 2 weeks ago
Money Today, 3 weeks ago
India Infoline, 1 month ago
Huffington Post India, 3 weeks ago

Japan Takes Aim at Ballooning Drug Prices as Costs Strain Budget

When two of the world's biggest pharmaceutical companies announced a tie-up in Japan, the country's $78 billion drug industry took note. In November, the country's largest drugmaker, Takeda Pharmaceutical Co., said itd separate its off-patent ...
 Bloomberg1 day ago
United News of India

Sun completes sale of two Ranbaxy divisions to Strides

NEW DELHI: Sun Pharmaceutical Industries today said it has completed the process of selling two divisions of erstwhile Ranbaxy Laboratories to Strides Shasun for Rs 165 crore. All the necessary formalities for closure of the said transaction have been ...
 Economic Times1 week ago Sun completes sale of 2 Ranbaxy divisions to Strides  Business Standard1 week ago Sun Pharma gets CCI nod for sale of 2 CNS divisions  United News of India2 weeks ago Sun Pharma gains on receiving CCI nod for sale of two CNS division to Strides Shasun  Finalaya.com2 weeks ago

Sun Pharma: Merger queered the pitch

The stock of the countrys largest drug maker, Sun Pharmaceutical, has lost over 10 per cent in the past year. This was on two counts. First, weak performance beginning March 2015 quarter following consolidation of Ranbaxys numbers into that of Sun Pharma came ...
 Business Line2 days ago

Pharma shares rally post Lupin Q3 results

Shares of pharmaceutical companies have rallied on the bourses after Lupin has reported a better-than-expected net profit for the quarter ended December 31, 2015 (Q3FY16). Lupin, Dishman Pharmaceuticals, Sequent Scientific, Granules India, ...
 Smart Investor4 days ago
Hindustan Times

Clampdown by US, EU regulators fail to dent pharma exports

Pharma exports rose 17% to `55,724 crore during the April-November period compared to a year-ago, even after a string of import alerts over quality issues and ban of 700 drugs by the European Union. The ban alone was expected to impact $1 billion ...
 Hindustan Times4 days ago
Financial Express

Sun Pharma rises on launching Imatinib Mesylate Tablets in USA

SENSEX 24315.90 223.10 0.91% NIFTY 7384.30 71.25 0.96% Industry: Medical/Healthcare Company Sun Pharmaceutical Industries Ltd Sun Pharmaceutical Industries is currently trading at Rs. 844.00, up by 9.65 points or 1.16% from ...
 Finalaya.com6 days ago Sun Pharma launches Imatinib Mesylate, incentives to US leukemia patients  Economic Times1 week ago Sun Pharmaceutical gains on launching Imatinib Mesylate Tablets in US  Financial Express6 days ago 2/2/16 - Sun Pharma launches Imatinib Mesylate in USA  Pharmacy Choice1 week ago

Aurobindo, Lupin, LT, JSW Steel should be on radar today

Stocks likely to be in the focus are: Larsen and Toubro, JSW Steel, Aurobindo Pharma, Lupin, Shriram Transport Finance Corporation, Jagran Prakashan, Marico, Suzlon Energy, Sun Pharmaceutical Industries, Godfrey Phillips India, Dr Reddys Laboratories, TVS ...
 Money Control1 week ago Here's why Cipla, IDBI Bk, Titan likely to be in focus today  Money Control1 month ago

Sun Pharma Advance Research's net loss rises to Rs. 41 cr in Q3

Sun Pharma Advanced Research Company (SPARC), belonging to Sun Pharmaceutical Industries, has suffered another setback during the third quarter ended December 2015 and its net loss increased to Rs. 41.02 crore from Rs. 18.91 crore in the ...
 PharmaBiz6 days ago SPARC slips on delay in start of royalty from 2 new drugs  Capital Market1 month ago
Business Standard India

Sun Pharma, Lupin launch generics in US

Sun Pharmaceuticals and Lupin have launched the generic versions of top selling drugs with 180 days sale exclusivity in the US market. The product launches will give a boost to the US business of the two companies, which have been hit by fewer ...
 Smart Investor1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
Get updated on latest news & your favorite topics right in your inbox!
More     Less